Edesa Biotech EDSA
NASDAQ EDSA
$2.75 -0.10 (-3.49%)
As of: Oct 22, 2026 · 2:31 PM EDT

Edesa Biotech (EDSA) Change in Other Operating Liabilities (2015 - 2018)

Updated

Analysis

Edesa Biotech (EDSA) Change in Other Operating Liabilities (2015 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,166.05 Bn 1,134.64 Bn 19.71 Bn -
2 Johnson & Johnson 647.70 Bn 567.56 Bn 17.30 Bn 2.69 Bn
3 AbbVie 503.26 Bn 476.37 Bn 12.70 Bn -
4 Merck 366.29 Bn 320.67 Bn 12.21 Bn -
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn -
6 Astrazeneca 268.96 Bn 242.64 Bn 12.86 Bn -
7 Amgen 242.14 Bn 197.54 Bn 7.24 Bn -32.00 Mn
8 Gilead Sciences 194.83 Bn 169.02 Bn 6.22 Bn -
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn -112.00 Mn
10 Edesa Biotech 24.76 Mn -20.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 80,000.00
Sep 30, 2016 -173,333.00
Mar 31, 2016 173,333.00
Dec 31, 2015 -173,333.00
Jun 30, 2015 173,333.00
Mar 31, 2015 -86,667.00
API Access

Edesa Biotech Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=EDSA&period=max&api_key=YOUR_API_KEY